CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis
Meta-analysis in patients with established coronary artery disease: the CERT2 ceramide-phospholipid score stratified major adverse cardiovascular event risk and added prognostic value beyond conventional lipids.
Evidence
—
Not Rated
Sample
—
subjects
Duration
—
study period
Journal
Journal of Clinical Lipidology
Mar 2022
Structured Methods
- Study Design
- Meta-analysis
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
Citations & References
Unknown authors (2022). CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis. Journal of Clinical Lipidology.
Source
Publisher
Journal
Journal of Clinical Lipidology
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
